SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses-Reference-Cited by-同舟云学术

SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses

Published:2023-12 Issue: Volume:98 Page:104893
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Puhach Olha,Bellon Mathilde,Adea Kenneth,Bekliz Meriem^ORCID,Hosszu-Fellous Krisztina,Sattonnet Pascale,Hulo Nicolas,Kaiser Laurent,Eckerle Isabella,Meyer Benjamin^ORCID

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference40 articles.

1. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021

2. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020

3. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression;Feikin;Lancet,2022

4. Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs;Bekliz;Nat Commun,2022

5. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron;Carreño;Nature,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of variants and vaccination on nasal immunity across three waves of SARS-CoV-2;2024-05-29

2. Durability of immune responses to SARS-CoV-2 infection and vaccination;Seminars in Immunology;2024-05

3. Enhanced mucosal B- and T-cell responses against SARS-CoV-2 after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant;2024-03-29

4. Impact of SARS-CoV-2 Vaccine and Infection History on Antiviral Immunity Post Breakthrough Infection;2024